Tango Therapeutics, Inc.
USD29.02
+1.48 (+5.37%)
CEO
Malte Peters
IPO Date
2020-09-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$27.85
Prev. Close
$27.54
Day Low
$27.61
Day High
$29.21
52W Low
$5.77
52W High
$34.39
Market Cap
$3.61B
Volume
1.93M
| -2.6 |
| 31 Dec 2023 | FY | 100.0% | -278.5% | -40.2% | -25.3% | 0.15 | 7.54 | -9.2 |
| 31 Dec 2022 | FY | 100.0% | -435.1% | -43.4% | -24.8% | 0.16 | 6.76 | -5.9 |
| 31 Dec 2021 | FY | 100.0% | -157.2% | -16.9% | -11.6% | 0.00 | 12.10 | -11.7 |
| 31 Dec 2020 | FY | 78.8% | -678.8% | -134.6% | -25.1% | 0.20 | 4.73 | -19.3 |
| 31 Dec 2019 | FY | -30.9% | -57.2% | -178.3% | -25.3% | 1.08 | 1.61 | -63.5 |
| -6.6 |
| 30 Sept 2025 | Q3 | 100.0% | 29.5% | 9.9% | 7.6% | 0.22 | 8.88 | 14.7 |
| 30 Jun 2025 | Q2 | 80.4% | -1221.4% | -28.8% | -16.3% | 0.26 | 4.75 | -3.6 |
| 31 Mar 2025 | Q1 | 100.0% | -739.5% | -23.9% | -14.5% | 0.22 | 6.26 | -0.9 |
| 31 Dec 2024 | Q4 | 100.0% | -915.0% | -18.9% | -11.9% | 0.18 | 6.98 | -2.2 |
| 30 Sept 2024 | Q3 | 100.0% | -251.3% | -12.7% | -8.3% | 0.16 | 8.00 | -7.2 |
| 30 Jun 2024 | Q2 | 100.0% | -128.6% | -10.3% | -6.7% | 0.15 | 7.49 | -9.5 |
| 31 Mar 2024 | Q1 | 100.0% | -585.9% | -14.3% | -9.3% | 0.14 | 8.23 | -5.4 |
| 31 Dec 2023 | Q4 | 100.0% | -566.4% | -12.2% | -7.6% | 0.15 | 7.54 | -7.7 |